ISPC (iSpecimen) Buyback Yield %: 0.00 (As of Jul. 03, 2026)


ISPC iSpecimen Inc ISPC
49 GF Score
Price $2.63
GF Value $6.69
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is iSpecimen Buyback Yield %?

iSpecimen ISPC -3.30% 49 Buyback Yield % is 0.00 as of Jul. 03, 2026. GuruFocus rates ISPC with a GF Score™ of 49/100 and a GF Value™ of $6.69 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 89 Medical Diagnostics & Research companies, iSpecimen ranks worse than 1123594.38% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

iSpecimen's current buyback yield was 0.00%.


iSpecimen Buyback Yield % Historical Data

* Premium members only.

The historical data trend for iSpecimen's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iSpecimen Buyback Yield % Chart

iSpecimen Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial -60.38 0.00 0.00 -42.44 -260.69

iSpecimen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -66.72 -16.38 -3.16 -260.69 0.00

ISPC vs BIAF, FUNI, IVRO: Buyback Yield % Comparison

For the Diagnostics & Research subindustry, iSpecimen's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iSpecimen Buyback Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, iSpecimen's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where iSpecimen's Buyback Yield % falls into.


ISPC
49GF Score
iSpecimen Inc ISPC
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iSpecimen Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

iSpecimen's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 5.75) / 2.205648
=-260.69%

iSpecimen's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 4.65976
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
iSpecimen (ISPC) has a Buyback Yield % of 0.00 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on iSpecimen and its competitors. According to the industry distribution chart, iSpecimen ranks #999999 out of 89 companies in the Medical Diagnostics & Research industry.
Is iSpecimen's Buyback Yield % too high?
iSpecimen's current Buyback Yield % is 0.00. Based on the distribution chart, iSpecimen ranks #999999 out of 89 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, iSpecimen has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does iSpecimen's Buyback Yield % compare to BIAF and FUNI?
According to the Medical Diagnostics & Research industry distribution chart, iSpecimen ranks #999999 out of 89 companies for Buyback Yield %. This places iSpecimen in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Diagnostics & Research company?
A good Buyback Yield % depends on the Medical Diagnostics & Research industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on iSpecimen and its competitors. iSpecimen's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iSpecimen stock overvalued right now?
Based on GuruFocus' analysis, iSpecimen (ISPC) is currently considered Possible Value Trap. The stock's GF Value™ is $6.69, compared to a current price of $2.63 — trading 60.7% below its estimated fair value. The current Buyback Yield % is 0.00. iSpecimen's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For iSpecimen (ISPC), the current Buyback Yield % is 0.00 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iSpecimen (ISPC) Overvalued in 2026?

Based on GuruFocus' analysis, iSpecimen stock appears to be undervalued. The current stock price of $2.63 is trading 60.7% below its estimated GF Value™ of $6.69. GuruFocus considers iSpecimen to be Possible Value Trap.

Key valuation signals for ISPC:

  • Buyback Yield %: 0.00
  • GF Value™: $6.69 vs. price of $2.63 (60.7% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the ISPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


iSpecimen Business Description

Address 8 Cabot Road, Suite 1800, Woburn, MA, USA, 01801
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
49GF Score

Get the complete analysis for ISPC

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.63
Price
$6.69
GF Value